Isolated Plasmacytoma of Bone: Clinical Trials

2 trials for Isolated Plasmacytoma of Bone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Isolated Plasmacytoma of Bone: new trials by email Literature Review of Isolated Plasmacytoma of Bone trials Research Report on Isolated Plasmacytoma of Bone

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma
dexamethasone, cisplatin, doxorubicin - Extramedullary Plasmacytoma, Isolated Plasmacytoma of Bone
Phase 2CompletedMargarida Magalhaes-Silverman412013-04-042022-05-11
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
beclomethasone dipropionate, placebo, tacrolimus - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia
Phase 2CompletedFred Hutchinson Cancer Center1402007-04-012021-02-03

Narrower conditions

Multiple Myeloma (2)  ·  Blast Crisis (1)  ·  Burkitt Lymphoma (1)  ·  Congenital Abnormalities (1)  ·  Graft vs Host Disease (1)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)  ·  Leukemia, Hairy Cell (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myeloid, Accelerated Phase (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1)  ·  Leukemia, Myeloid, Chronic-Phase (1)  ·  Leukemia, Myelomonocytic, Chronic (1)

Broader conditions

Blood Protein Disorders (2)  ·  Cardiovascular Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hemorrhagic Disorders (2)  ·  Hemostatic Disorders (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Plasma Cell (2)  ·  Paraproteinemias (2)  ·  Vascular Diseases (2)  ·  Amyloidosis (1)

Interventions

Beclomethasone (1)  ·  Bortezomib (1)  ·  Calcium Dobesilate (1)  ·  Cisplatin (1)  ·  Cyclophosphamide (1)  ·  Dexamethasone (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Melphalan (1)  ·  Methotrexate (1)  ·  Tacrolimus (1)  ·  Thalidomide (1)  ·  merphos (1)

Sponsors

Fred Hutchinson Cancer Center (1)  ·  Margarida Magalhaes-Silverman (1)

Countries

United States (2)

Top investigators

Margarida Magalhaes-Silverman, MD (1)  ·  Paul Martin (1)

NIH funding

P30CA086862 (1)